Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval – Seeking Alpha
Bloomberg |
Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval
Seeking Alpha Crispr Therapeutics (NASDAQ:CRSP) is one of the three companies that specialises in CRISPR-Cas9 genome editing technique. All three companies had spectacular IPOs but presently Crispr Therapeutics is the only one that has retained the initial euphoria … Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold FDA halts one of the first human CRISPR studies before it begins Is Crispr Therapeutics Stock a Bad News Buy? |
